๐Ÿ”ด Today is World Blood Cancer Day ๐Ÿ”ด
May 28, 2025

At Pharmidex, we stand in solidarity with all patients, families, and healthcare professionals impacted by blood cancers.
This day is a powerful reminder of the urgent need for continued innovation, collaboration, and compassion in the fight against these life-threatening diseases.

Through our cutting-edge preclinical services, including:

  • PK/ADME studies
  • CNS penetration & efficacy models
  • in vivo/in vitro pharmacology
  • bioanalytical and regulatory support

๏ปฟ

we contribute to the development of safer, more effective therapies for blood cancers.

๐Ÿงฌ We’re proud to collaborate with leading biopharma companies, academic institutions, and charities to accelerate the discovery and delivery of new treatments.

โค๏ธ Today, we renew our commitment to this mission working towards a future where every patient has access to a cure.


๐Ÿ”— Learn more and support the cause: https://www.dkms.org.uk

July 17, 2025
We’re growing and looking for passionate scientists to join our dynamic team. If you're excited by impactful science and meaningful collaboration, check out our latest roles: ๐Ÿ”ฌ Bioanalytical Scientist (Permanent) Work with LC-MS/MS platforms to support preclinical and clinical bioanalysis across a wide range of therapeutic areas. ๐Ÿงซ Histology Technician (3-Month FTC, Full or Part-Time) Be at the heart of tissue processing for in vivo and toxicology studies GLP experience welcome, flexibility offered. ๐Ÿงช Scientist / Senior Scientist – Immunology (Full-Time) Advance autoimmune disease research through innovative T-cell and cytokine profiling assays. ๐Ÿ’ก Why Pharmidex? โœ” 20+ years of scientific excellence โœ” Collaborative, science-led culture โœ” Diverse therapeutic expertise โœ” Real-world impact through discovery and development ๐Ÿ“ฉ Ready to apply or want to learn more? Visit www.pharmidex.com/careers or email your CV to [email protected] Applications are reviewed on a rolling basis, early interest encouraged! ๏ปฟ Let’s shape the future of drug discovery together.
July 15, 2025
We’re excited to introduce our GLP-standard intracranial dosing platform delivering targeted compounds directly to the brain for more precise CNS preclinical studies. โœ… Bypasses the blood-brain barrier โœ… Reduces systemic side effects โœ… Enhances translational relevance Now fully GLP-validated with: Documented SOPs & equipment Verified dose placement MHRA-audited compliance ๐Ÿ“ˆ Benefits: Regulatory-ready data, better reproducibility, and lower repeat study costs. ๐Ÿ‘‰ Swipe the carousel to learn more. ๐Ÿ”— www.pharmidex.com
New Insights from Pharmidex: Tumour Microdialysis in Glioblastoma
July 10, 2025
We’re excited to share our latest work on tumour microdialysis, a powerful technique for measuring unbound, pharmacologically active drug concentrations directly within brain tumours like glioblastoma. Unlike systemic plasma levels, microdialysis provides a true picture of drug penetration into the tumour helping to uncover heterogeneous distribution and the impact of the blood-tumour barrier. Our approach involves precise stereotaxic surgery, tumour validation, and sampling from both tumour and healthy brain tissue enabling direct, comparative pharmacokinetic analysis. ๐Ÿ“Š The results? Significant differences in drug exposure between tumour core and surrounding tissue. ๐Ÿ‘‰ Swipe through the carousel to explore our process and findings. ๏ปฟ ๐Ÿ”— www.pharmidex.com
More Posts